Company intelligence / Profile preview
BLR Bio
North Chicago, Illinois, United Statesblrbio.com ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Preclinical
01
Overview
BLR Bio’s lead candidate, BLR200, shows strong anti-fibrotic effects in preclinical models of lung disease including systemic sclerosis-associated lung fibrosis. It reduces key markers such as Ashcroft scores, collagen levels, fibronectin, and profibrotic CCN proteins more effectively than existing therapies. The company also develops a cancer therapy candidate BLR100 that targets cancer-associated fibroblasts to enhance chemotherapy efficacy without increasing side effects. Recent presentations at major conferences highlight these advances[1][3][5][6].
- Therapeutic areas
- PulmonologyRheumatologyOncology
- Modalities
- Peptide-based therapeuticsFibroblast-targeting agentsCancer Activated Fibroblasts targeting agents
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Collaborations with academic institutions such as University of Saskatchewan and University of Michigan; partnership with a European diagnostics leader for NASH diagnostic development[6]. Also incubated at Rosalind Franklin University's Helix51 incubator[3][5].
Beyond the preview
Go deeper on BLR Bio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BLR Bio.